Drug and Venom Allergy in Mastocytosis

被引:7
作者
Giannetti, Matthew P. [1 ,2 ,4 ]
Nicoloro-SantaBarbara, Jennifer [2 ,3 ]
Godwin, Grace [1 ]
Middlesworth, Julia [1 ]
Espeland, Andrew [1 ]
Castells, Mariana C. [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Div Allergy & Clin Immunol, 41 Ave Louis Pasteur,Alumni Hall,Room 303, Boston, MA 02115 USA
[2] Harvard Med Sch, 41 Ave Louis Pasteur,Alumni Hall,Room 303, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Psychiat, 41 Ave Louis Pasteur,Alumni Hall,Room 303, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Div Allergy & Clin Immunol, 60 Fenwood Rd,Hale Bldg Transformat Med,5th floor, Boston, MA 02132 USA
关键词
Nonsteroidal antiinflammatory drugs (NSAIDs); Antibiotics; Vaccines; Perioperative anaphylaxis; MAST-CELL ACTIVATION; SPANISH NETWORK; TRYPTASE LEVELS; SYSTEMIC MASTOCYTOSIS; INDUCED ANAPHYLAXIS; CLINICAL-FEATURES; RISK; IMMUNOTHERAPY; DISORDERS; HYPERSENSITIVITY;
D O I
10.1016/j.iac.2023.04.002
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
"I would like to challenge you with ibuprofen and if you have no reaction, I will remove the label of "Allergy to NSAIDS." You may take aspirin, ibuprofen, and other drugs needed for arthritis. Protocols for skin testing and challenges leading to drug delabeling of mastocytosis patients are needed.Although some patients with mastocytosis need protection when exposed to NSAIDs, opioids, vaccines, antibiotics, and RCM, better diagnostic tools are needed to assess the populations at risk. Personalized diagnosis should be provided to patients aimed at labeling and delabeling drugs allergies. Patients with mastocytosis should be evaluated for tolerance to drugs before acute situations, particularly children and pregnant women.New therapies such as tyrosine kinase inhibitors hope to address the number and activation of mast cells and are currently in clinical trials. Whether such medications would improve tolerance of drugs-inducing reactions will need to be addressed.
引用
收藏
页码:699 / 710
页数:12
相关论文
共 60 条
[11]   Hymenoptera Anaphylaxis as a Clonal Mast Cell Disorder [J].
Bonadonna, Patrizia ;
Scaffidi, Luigi .
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2018, 38 (03) :455-+
[12]   Drug Allergy in Mastocytosis [J].
Bonadonna, Patrizia ;
Lombardo, Carla .
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2014, 34 (02) :397-+
[13]   Mastocytosis and insect venom allergy [J].
Bonadonna, Patrizia ;
Zanotti, Roberta ;
Mueller, Ulrich .
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 10 (04) :347-353
[14]   Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels [J].
Bonadonna, Patrizia ;
Perbellini, Omar ;
Passalacqua, Giovanni ;
Caruso, Beatrice ;
Colarossi, Sabrina ;
Dal Fior, Daniela ;
Castellani, Luca ;
Bonetto, Chiara ;
Frattini, Francesco ;
Dama, Annarita ;
Martinelli, Giovanni ;
Chilosi, Marco ;
Senna, Gianenrico ;
Pizzolo, Giovanni ;
Zanotti, Roberta .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (03) :680-686
[15]   Prevention and treatment of hymenoptera venom allergy:: guidelines for clinical practice [J].
Bonifazi, F ;
Jutel, M ;
Biló, BM ;
Birnbaum, J ;
Muller, U .
ALLERGY, 2005, 60 (12) :1459-1470
[16]   Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients [J].
Brockow, K. ;
Jofer, C. ;
Behrendt, H. ;
Ring, J. .
ALLERGY, 2008, 63 (02) :226-232
[17]   Skin testing in patients with hypersensitivity reactions to iodinated contrast media - a European multicenter study [J].
Brockow, K. ;
Romano, A. ;
Aberer, W. ;
Bircher, A. J. ;
Barbaud, A. ;
Bonadonna, P. ;
Faria, E. ;
Kanny, G. ;
Lerch, M. ;
Pichler, W. J. ;
Ring, J. ;
Cernadas, J. Rodrigues ;
Tomaz, E. ;
Demoly, P. ;
Christiansen, C. .
ALLERGY, 2009, 64 (02) :234-241
[18]   Risk of solid cancer, cardiovascular disease, anaphylaxis, osteoporosis and fractures in patients with systemic mastocytosis: A nationwide population-based study [J].
Broesby-Olsen, Sigurd ;
Farkas, Dora Kormendine ;
Vestergaard, Hanne ;
Hermann, Anne Pernille ;
Moller, Michael Boe ;
Mortz, Charlotte Gotthard ;
Kristensen, Thomas Kielsgaard ;
Bindslev-Jensen, Carsten ;
Sorensen, Henrik Toft ;
Frederiksen, Henrik .
AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (11) :1069-1075
[19]   ASPIRIN IDIOSYNCRASY IN SYSTEMIC MAST-CELL DISEASE - A NEW LOOK AT MEDIATOR RELEASE DURING ASPIRIN DESENSITIZATION [J].
BUTTERFIELD, JH ;
KAO, PC ;
KLEE, GG ;
YOCUM, MW .
MAYO CLINIC PROCEEDINGS, 1995, 70 (05) :481-487
[20]   Prevention of Mast Cell Activation Disorder-Associated Clinical Sequelae of Excessive Prostaglandin D2 Production [J].
Butterfield, Joseph H. ;
Weiler, Catherine R. .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2008, 147 (04) :338-343